SCHEMBL414560

SCHEMBL414560

CCCN(CCC)S(=O)(=O)c1ccc(N)cc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 10/20 0.62
CA12 O43570 9/20 0.62
CA2 P00918 5/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
RAB9A P51151 2/20 0.62
SLC22A6 Q4U2R8 1/20 0.62
SLC22A8 Q8TCC7 1/20 0.62
ABCC2 Q92887 1/20 0.62
SLC22A12 Q96S37 1/20 0.62
UGT1A7 Q9HAW7 1/20 0.62
SLC22A11 Q9NSA0 1/20 0.62
CA1 P00915 8/20 0.57
LMNA P02545 3/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
GAA P10253 1/20 0.52
HTT P42858 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119211 0.92 SMN1; SMN2 (0.58) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL10693896 0.89 CA12 (0.54) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL11518024 0.89 CA9 (0.55) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL27503338 0.86 CA12 (0.51) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL18780662 0.86 CA12 (0.51) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL28049156 0.85 CA12 (0.60) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL3314209 0.84 LMNA (0.70) CA9CA12CA2SMN1; SMN2RAB9A
Ditolamide SCHEMBL2110790 0.82 CA9 (0.64) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL5018945 0.81 CA9 (0.58) CA9CA12CA2SMN1; SMN2RAB9A
SCHEMBL24162488 0.81 KMT2A (0.74) CA9CA12CA2SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117156877-A Perovskite solar cell and preparation method thereof 武汉万度光能研究院有限责任公司 2023-12-01 CN claimed
US-8142804-B2 Pest control sheet MAKHTESHIM CHEMICAL WORKS LTD. (IL) 2012-03-27 US claimed
EP-0257771-A1 Herbicidal method using diflufenican RHONE-POULENC AGRICULTURE LTD. (GB) 1988-03-02 EP claimed
US-12543674-B2 Embryogenesis factors for cellular reprogramming of a plant cell PIONEER HI-BRED INTERNATIONAL, INC. (US) 2026-02-10 US disclosed
US-20250277230-A1 PARTHENOGENESIS METHODS AND COMPOSITIONS PIONEER HI-BRED INTERNATONAL, INC. (US) 2025-09-04 US disclosed
US-20250115924-A1 SYSTEMS AND METHODS FOR CELLULAR REPROGRAMMING OF A PLANT CELL PIONEER HI-BRED INTERNATIONAL, INC. (US) 2025-04-10 US disclosed
US-20250115927-A1 METHODS FOR CLONAL PLANT PRODUCTION PIONEER HI-BRED INTERNATIONAL, INC. (US) 2025-04-10 US disclosed
US-20250101453-A1 METHODS OF PARTHENOGENIC HAPLOID INDUCTION AND HAPLOID CHROMOSOME DOUBLING PIONEER HI-BRED INTERNATIONAL, INC. (US) 2025-03-27 US disclosed
CN-119431239-A Compounds, pharmaceutical compositions, kits and uses thereof 密执安大学评议会 2025-02-14 CN disclosed
US-12146147-B2 Methods for clonal plant production PIONEER HI-BRED INTERNATIONAL, INC. (US) 2024-11-19 US disclosed
CN-113710241-B Substituted bicyclic and tetracyclic quinones and related methods of use 密执安大学评议会 2024-11-15 CN disclosed
US-20040063705-A1 Substituted pyrimidinyl derivatives and methods of use AMGEN INC. 2004-04-01 US disclosed
WO-2003105904-A1 CALIXARENES FOR USE AS EXCIPIENT FOR AN ACTIVE SUBSTANCE DORMANN JOERG MARTIN (DE) 2003-12-24 WO disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed
CN-1016963-B HERBICIDE COMPOSITION CONTG. BENZENE SULFONAMIDE AS ACTIVE INGREDIENT MITSUBISHI CHEM IND (JP) 1992-06-10 CN disclosed
CN-1036564-A Sulfanilamide (SN) and contain the weedkiller of sulfanilamide (SN) as activeconstituents MITSUBISHI CHEM IND (JP) 1989-10-25 CN disclosed
EP-0243522-B1 SYSTEMIC HERBICIDAL COMPOSITIONS AND METHODS OF USE UNION OIL COMPANY OF CALIFORNIA (US) 1989-09-13 EP disclosed
EP-0330137-A1 Intermediate compounds for the preparation of 1,2,4-triazolo [1,5-a]pyrimidine-2-sulfonamides DowElanco (US) 1989-08-30 EP disclosed
EP-0257771-A1 Herbicidal method using diflufenican RHONE-POULENC AGRICULTURE LTD. (GB) 1988-03-02 EP disclosed
EP-0020052-A1 Novel substituted nitrodiphenyl ethers, herbicidal compositions containing them, processes for the preparation thereof and the use thereof for combating weeds ROHM AND HAAS COMPANY (US) 1980-12-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063705-A1 Substituted pyrimidinyl derivatives and methods of use DPYD, TYMP, TPMT CA9 1230/4885CA12 2294/4885CA2 2132/4885
US-12543674-B2 Embryogenesis factors for cellular reprogramming of a plant cell CCNB2, CCNB1, CCNB3 CA9 4738/4885CA12 4001/4885CA2 3910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.